Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04596761 · ClinicalTrials.gov registry record · NA

ToothWave Calculus Reduction and Accumulation Prevention Study

A NA study of Gingivitis and Plaque, sponsored by Home Skinovations.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04596761 is a NA study of Gingivitis and Plaque that has completed, run by Home Skinovations. The registered enrollment target is 90 participants, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04596761, a NA study of Gingivitis and Plaque, has completed, sponsored by Home Skinovations.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The objective of the study is to evaluate the safety and efficacy of the home-use device ToothWave (Model H7001) for calculus reduction and the prevention of calculus accumulation.

Interventions

  • DEVICE Control placebo with no RF
  • DEVICE RF-utilizing powered toothbrush

Study Locations (1)

Indiana

  • Salus Research - Fort Wayne

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2020-07-15
Est. Completion 2020-12-10
Phase NA

Sponsor

Home Skinovations

6 total trials

What the Registry Record Tells You About NCT04596761

The ClinicalTrials.gov registry entry for NCT04596761 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (61% lower). The listed sponsor is Home Skinovations, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which Control placebo with no RF is the first listed.

NCT04596761 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04596761 about?

NCT04596761 is a clinical study titled "ToothWave Calculus Reduction and Accumulation Prevention Study". The objective of the study is to evaluate the safety and efficacy of the home-use device ToothWave (Model H7001) for calculus reduction and the prevention of calculus accumulation.

What is the current status of trial NCT04596761?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2020-07-15. Estimated completion is 2020-12-10.

What conditions does trial NCT04596761 study?

This clinical trial studies the following conditions: Gingivitis, Plaque, Calculus, Dental.

What interventions are being tested in trial NCT04596761?

The interventions under investigation include: Control placebo with no RF (DEVICE), RF-utilizing powered toothbrush (DEVICE).

Who is sponsoring clinical trial NCT04596761?

This trial is sponsored by Home Skinovations, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04596761 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.